Sign in

CIK 0001746473

  • Non-accelerated filer
  • Smaller reporting company

PLIANT THERAPEUTICS, INC.

Sign in to watch
Ticker
PLRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
474272481
Phone
+1 650-481-6770
Business address
331 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO, CA, 94080
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2022-11-29 Third Rock Ventures III, L.P. 10% owner Other disposition −2,000,000 1,839,160
2022-10-25 Lefebvre Eric Chief Medical Officer Sale −5,000 $25.05 $125K 133,437
2022-09-20 Third Rock Ventures III, L.P. 10% owner Other disposition −2,000,000 3,839,160
2022-09-14 Knobil Katharine Director Grant or award · Stock Option (Right to Buy) +30,000 30,000
2022-09-12 Coulie Bernard President and CEO Exercise or conversion +12,502 $2.08 $26K 71,775
2022-09-12 Coulie Bernard President and CEO Sale −12,502 $22.54 $282K 59,273
2022-09-12 Coulie Bernard President and CEO Exercise or conversion · Stock Option (right to buy) −12,502 297,380
2022-07-12 Coulie Bernard President and CEO Exercise or conversion +12,498 $2.08 $26K 71,771
2022-07-12 Coulie Bernard President and CEO Sale −12,498 $22.50 $281K 59,273
2022-07-12 Coulie Bernard President and CEO Exercise or conversion · Stock Option (right to buy) −12,498 309,882
2022-07-11 Lefebvre Eric Chief Medical Officer Sale −3,000 $20.00 $60K 138,436
2022-07-11 Coulie Bernard President and CEO Exercise or conversion +15,000 $2.08 $31K 74,273
2022-07-11 Coulie Bernard President and CEO Sale −15,000 $22.50 $338K 59,273
2022-07-11 Coulie Bernard President and CEO Exercise or conversion · Stock Option (right to buy) −15,000 322,380
2022-06-16 PYOTT DAVID E I Director Grant or award · Stock Option (right to buy) +15,000 15,000
2022-06-16 Huh Hoyoung Director Grant or award · Stock Option (right to buy) +15,000 15,000
2022-06-16 Exter Neil Director Grant or award · Stock Option (right to buy) +15,000 15,000
2022-06-16 Curnutte John T Director Grant or award · Stock Option (right to buy) +15,000 15,000
2022-06-16 CROWELL GAYLE A Director Grant or award · Stock Option (right to buy) +15,000 15,000
2022-06-16 Bruhn Suzanne Louise Director Grant or award · Stock Option (right to buy) +15,000 15,000

Page 14 of 19 · 379 trades